Products | 國產維生素膠囊大剖析

Auniqueportfolioofhighqualityanddifficult-to-makepharmaceuticalproductsfuelsourtargetedgrowthstrategy.Alvogenhasover200strategicallyselected ...

We deploy a multidimensional strategy to build up a unique portfolio to enable profitable growth.

With our internal R&D resources and state-of-art manufacturing facilities, we produce and promote an unique portfolio of high quality and difficult-to-make specialty generics in the filed of cardiology, nephrology, central nervous system, women health, and anti-obesity with a primary focus on addressing the fast-growing oncology market. We always keep more than 20 strategically selected projects in development and registrations across Asia and the US and has more than 250 products in the market.

We also continuously invest in diversifying our product portfolio with tail-end brands, biosimilars, NCEs, and over-then-counter (OTC) products via product acquisition or licensing-in partnership with support from external resources.